Titlebook: Hydrogen Sulfide in Kidney Diseases; A Novel Pharmacother George J. Dugbartey,Alp Sener Book 2023 The Editor(s) (if applicable) and The Aut

取回

Progesterone

減弱不好

間接

Hydrogen Sulfide Against Ischemia-Reperfusion Injury in Transplantation of Kidney and Other Transplor factor that increases acute tubular necrosis, decreases graft survival, and delays renal graft function. This complicates graft quality, posttransplant patient care, and kidney transplantation outcomes and therefore undermines the success of kidney transplantation. In this chapter, we present rec

Vsd168

FDA-Approved Hydrogen Sulfide Donor Drug and Its Clinical Applications in Nephrology,hird member of the gasotransmitter family. STS is currently used in the clinical treatment of acute cyanide poisoning, cisplatin toxicities in cancer therapy, and calciphylaxis in dialysis patients. Burgeoning evidence shows that STS has antioxidant and anti-inflammatory properties, making it a pote

NAUT

挫敗

George J. Dugbartey,Alp SenerCovers the latest experimental evidence of hydrogen sulfide for cisplatin-induced acute kidney injury.Provides updates on hydrogen sulfide as a novel pharmacotherapy for chronic kidney disease.Present

AUGUR

carbohydrate

978-3-031-44043-4The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

迷住